Sprinklr, Inc.

Fundamentals6.0
Price Action4.0
News Sentiment5.0
AI Rating
6.0

Key Drivers

  • Strong Liquidity
  • Thin Margins
  • Heavy Expenses

AI
AI Summary

6.0

CXM is no longer a turnaround story; the investable question is whether improving execution and cash generation can translate into faster revenue growth and a durable rerating, because without real acceleration the still-demanding valuation and overhead supply near $5.25-$5.45 are likely to cap upside.

CashFlow
Valuation
Watchlist‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong Liquidity
  • Thin Margins
  • Heavy Expenses

CXM combines strong liquidity and cash generation with manageable leverage, but modest net profitability and a demanding valuation mean the story is more about financial resilience than earnings power.

CashFlow
Overvalued

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Support Holding
  • Resistance Rejection
  • Short-Term Bounce

Over the last month, CXM is range-bound to slightly bearish, with $4.90–$5.00 support holding but repeated rejections near $5.25–$5.45 keeping the stock capped until it can reclaim $5.25.

rangebound
bearish
Support Level: $4.90–$5.00
Resistance Level: $5.25–$5.45

Rebounded from $4.89 to $5.11, showing short-term buying interest

Sentiment & News

5.0

Key News Insights:

  • Earnings catalyst
  • Healthcare leadership
  • AI CXM demand

Sprinklr's upcoming Q1 earnings update and Alorica's healthcare CXM recognition highlight continued momentum in AI-driven and healthcare-focused customer experience management.

CXM
HealthcareCXM

The news reinforces ongoing investor and client interest in CXM names with clear operational execution and sector-specific differentiation